Difference between revisions of "Template:New Product"
From Bioblast
Cocco Paolo (talk | contribs) |
|||
| Line 1: | Line 1: | ||
<div style="display: table; style="width: 95%; border-radius: 6px; background-color: white; border: 1px solid #090982; margin: 0.5em 1em 0 1em; padding: 6px; box-shadow: 0px 0px 5px #090982;> | <div style="display: table; style="width: 95%; border-radius: 6px; background-color: white; border: 1px solid #090982; margin: 0.5em 1em 0 1em; padding: 6px; box-shadow: 0px 0px 5px #090982;> | ||
<table> | <table> | ||
[[Image:Logo_OROBOROS_INSTRUMENTS.jpg|right|35px|link=http://wiki.oroboros.at/index.php/OROBOROS_INSTRUMENTS |Oroboros]] | [[Image:Logo_OROBOROS_INSTRUMENTS.jpg|right|35px|link=http://wiki.oroboros.at/index.php/OROBOROS_INSTRUMENTS |Oroboros]] | ||
Latest revision as of 16:45, 12 November 2019
- The new MitoKit-CII
| The cell permeable compounds MitoKit-CII, including succinate-nv and malonate-nv, are the first generation of NeuroVive Pharmaceutical AB's prodrugs and have been developed to stimulate or inhibit Complex II of the respiratory electron transfer system in living cells. The MitoKit-CII will expand the toolbox for evaluating the role of mitochondria in disease.
|
 |
